- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 59.88M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 62.72M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 38.24M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $184K |
| Capex | Q1 2026 · Mar 31, 2025 | $112K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$22.17M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$16.62M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $15M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $28.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $34.69M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.69M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $16.74M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $49.69M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $51.48M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $96.21M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $107.91M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $100.66M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $114.86M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.49 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.49 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.37M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.26M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $15.78M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $13.48M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$20.69M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$18.76M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$22.08M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$18.92M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $32K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $44K |
| Revenue | Q1 2026 · Mar 31, 2026 | $110K |
| Revenue | Q1 2026 · Mar 31, 2025 | $868K |